Ginkgo Bioworks director awarded 25,000 RSUs
Kosuri Sri reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Kosuri Sri reported acquisition or exercise transactions in this Form 4 filing.
Ginkgo Bioworks Holdings, Inc. director Sri Kosuri received a grant of 25,000 restricted stock units on June 11, 2026 as equity compensation. Each RSU represents a contingent right to receive one share of the company’s Class A common stock. The RSUs will vest on the earlier of June 11, 2027 or the day immediately before the next annual meeting after the grant date, provided Kosuri continues to serve as a non-employee director through that vesting date. This is a stock-based award, not an open-market share purchase or sale.
Insider Trade Summary
Grant/Award: 25,000 shares
Grant/Award
1 txn
Insider
Kosuri Sri
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,000 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 25,000 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.
Key Figures
RSUs granted: 25,000 RSUs
Underlying shares: 25,000 shares
Shares after transaction: 25,000 derivative units
+1 more
4 metrics
RSUs granted
25,000 RSUs
Grant on June 11, 2026 to non-employee director
Underlying shares
25,000 shares
Class A Common Stock underlying the RSUs
Shares after transaction
25,000 derivative units
Total RSUs held following the grant
Vesting date
June 11, 2027
Latest possible vesting date, or earlier before next annual meeting
Key Terms
Restricted Stock Units, Class A Common Stock, Amended and Restated Non-Employee Director Compensation Program, vest
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"to receive one share of the Issuer's Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Amended and Restated Non-Employee Director Compensation Program financial
"In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program"
vest financial
"the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ginkgo Bioworks (DNA) director Sri Kosuri report in this Form 4?
Sri Kosuri reported receiving 25,000 restricted stock units as equity compensation. These RSUs are a grant, not a market purchase, and each can convert into one share of Class A common stock if vesting conditions are met.
How many RSUs did Sri Kosuri receive from Ginkgo Bioworks (DNA)?
Sri Kosuri received 25,000 restricted stock units. Each RSU represents a contingent right to one share of Class A common stock, giving him a potential future equity interest subject to vesting conditions and continued board service.
When do Sri Kosuri’s RSUs at Ginkgo Bioworks (DNA) vest?
The RSUs vest on the earlier of June 11, 2027, or the day immediately before the next annual meeting after grant. Vesting is conditioned on Kosuri’s continued service as a non-employee director through the applicable vesting date under the company’s program.
Is this Ginkgo Bioworks (DNA) Form 4 a stock purchase by Sri Kosuri?
No, this Form 4 reflects a grant of restricted stock units, not an open-market stock purchase. The RSUs were awarded at no cash cost as part of non-employee director compensation, with future delivery of shares subject to vesting conditions.
What does each RSU granted to Sri Kosuri by Ginkgo Bioworks (DNA) represent?
Each RSU represents a contingent right to receive one share of Class A common stock. Actual share delivery occurs only if the RSUs vest under the terms of the non-employee director compensation program and service conditions are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates